FMC - Mason City is a medicare approved dialysis facility center in Mason City, Iowa and it has 21 dialysis stations. It is located in Cerro Gordo county at 910 N Eisenhower Ave, Mason City, IA, 50401. You can reach out to the office of FMC - Mason City at (641) 428-5332. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Mason City has the following ownership type - Profit. It was first certified by medicare in August, 2016. The medicare id for this facility is 162562 and it accepts patients under medicare ESRD program.
Name | FMC - Mason City |
---|---|
Location | 910 N Eisenhower Ave, Mason City, Iowa |
No. of Dialysis Stations | 21 |
Medicare ID | 162562 |
Managed By | Fresenius Medical Care |
Ownership Type | Profit |
Late Shifts | No |
910 N Eisenhower Ave, Mason City, Iowa, 50401 | |
(641) 428-5332 | |
Not Available |
News Archive
Whether a tiny yellow pigment is the main thing standing between many older people and macular degeneration is under study at the Medical College of Georgia.
Postmenopausal women who quit smoking reduced their risk of heart disease, regardless of whether they had diabetes, according to a new study conducted by Juhua Luo, an epidemiologist at the Indiana University School of Public Health-Bloomington.
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced its financial results for the first quarter ended January 31, 2010.
A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).
› Verified 7 days ago
NPI Number | 1548616774 |
Organization Name | Fresenius Kidney Care Mason City |
Doing Business As | Fresenius Kidney Care North Iowa, Llc |
Address | 910 N Eisenhower Ave Mason City, Iowa, 50401 |
Phone Number | (641) 428-5332 |
News Archive
Whether a tiny yellow pigment is the main thing standing between many older people and macular degeneration is under study at the Medical College of Georgia.
Postmenopausal women who quit smoking reduced their risk of heart disease, regardless of whether they had diabetes, according to a new study conducted by Juhua Luo, an epidemiologist at the Indiana University School of Public Health-Bloomington.
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced its financial results for the first quarter ended January 31, 2010.
A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).
› Verified 7 days ago
Dialysis patients with Hemoglobin data | 36 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 25 |
News Archive
Whether a tiny yellow pigment is the main thing standing between many older people and macular degeneration is under study at the Medical College of Georgia.
Postmenopausal women who quit smoking reduced their risk of heart disease, regardless of whether they had diabetes, according to a new study conducted by Juhua Luo, an epidemiologist at the Indiana University School of Public Health-Bloomington.
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced its financial results for the first quarter ended January 31, 2010.
A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 45 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 413 |
Percentage of adult patients getting regular hemodialysis at the center | 93 |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Whether a tiny yellow pigment is the main thing standing between many older people and macular degeneration is under study at the Medical College of Georgia.
Postmenopausal women who quit smoking reduced their risk of heart disease, regardless of whether they had diabetes, according to a new study conducted by Juhua Luo, an epidemiologist at the Indiana University School of Public Health-Bloomington.
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced its financial results for the first quarter ended January 31, 2010.
A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Mason City with elevated calcium levels.
Patients with hypercalcemia | 47 |
Hypercalcemia patient months | 428 |
Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
Patients with Serumphosphor | 52 |
Patients with Serumphosphor less than 3.5 mg/dL | 7 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 20 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 31 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 31 |
Patients with Serumphosphor greater than 7 mg/dL | 10 |
News Archive
Whether a tiny yellow pigment is the main thing standing between many older people and macular degeneration is under study at the Medical College of Georgia.
Postmenopausal women who quit smoking reduced their risk of heart disease, regardless of whether they had diabetes, according to a new study conducted by Juhua Luo, an epidemiologist at the Indiana University School of Public Health-Bloomington.
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced its financial results for the first quarter ended January 31, 2010.
A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 58 |
Patient months included in arterial venous fistula and catheter summaries | 352 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 57 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 34 |
News Archive
Whether a tiny yellow pigment is the main thing standing between many older people and macular degeneration is under study at the Medical College of Georgia.
Postmenopausal women who quit smoking reduced their risk of heart disease, regardless of whether they had diabetes, according to a new study conducted by Juhua Luo, an epidemiologist at the Indiana University School of Public Health-Bloomington.
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced its financial results for the first quarter ended January 31, 2010.
A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).
› Verified 7 days ago